Topics

Opsidio, LLC Company Profile

01:08 EST 23rd January 2020 | BioPortfolio

Opsidio, LLC is a preclinical stage biopharmaceutical company developing monoclonal antibodies to treat fibrotic diseases. Opsidio is headquartered in Bryn Mawr, PA with additional facilities in Ann Arbor, MI. For further information, please contact Martin Phillips or Jim Jogerst, at info@opsidio.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Opsidio, LLC

Opsidio, LLC is a preclinical stage biopharmaceutical company developing monoclonal antibodies to treat fibrotic diseases. Opsidio is headquartered in Bryn Mawr, PA with additiona...

More Information about "Opsidio, LLC" on BioPortfolio

We have published hundreds of Opsidio, LLC news stories on BioPortfolio along with dozens of Opsidio, LLC Clinical Trials and PubMed Articles about Opsidio, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Opsidio, LLC Companies in our database. You can also find out about relevant Opsidio, LLC Drugs and Medications on this site too.

Quick Search

Relevant Topic

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...


Corporate Database Quicklinks



Searches Linking to this Company Record